ACUNAV Ultrasound Catheter

Ultrasound Catheter

Increase insight into the heart during transseptal punctures. The ACUNAV^™ Catheter provides high resolution 2D grayscale and Doppler models that help better understand structural orientation, visualize cardiac chamber borders and verify tissue contact.

The ACUNAV^™ Catheter is intended for intracardiac and intraluminal visualization of cardiac and great vessel anatomy and physiology as well as visualization of other devices in the heart. Adverse events related to cardiac catheterization have been documented. It shall be more clearly stated that ultrasound help mitigating the risk of complications but it does not avoid any. There is always a risk for the patient.
ACUNAV^™ is a trademark of Siemens Medical Solutions USA, Inc.

Features & Benefits:

Precise, real-time visualization of anatomic and physiologic detail
Enhanced insight into proximal anatomy and potential hazards
Doppler imaging of blood flow and velocity, and myocardial wall motion
Four-way steering to 160°, for precise positioning and new views of the heart

ACUNAV^™
Ultrasound Catheter

Ordering Number	Description	Size	Insertion Length	Length	Compatability
10135936	ACUNAV^™ 8F Siemens Catheter	8F	90 cm	90 cm	Siemens Sequoia^™ Cypress^™, Acuson X300^™, X700^™, SC2000^™
08255790	ACUNAV^™ 10F Siemens Catheter	10F	90 cm		Siemens Sequoia^™ Cypress^™, Acuson X300^™, X700^™, SC2000^™
10043342	ACUNAV^™ 10F GE Catheter	10F	90 cm	90 cm	GE Vivid^™ i, GE Vivid^™ q
10135910	ACUNAV^™ 8F GE Catheter	8F	90 cm	90 cm	GE Vivid^™ i, GE Vivid^™ q
R10135936	Certified Performance ACUNAV^™ 8F Siemens Catheter	8F	90 cm		Siemens Sequoia^™ Cypress^™, Acuson X300^™, X700^™, SC2000^™
R08255790	Certified Performance ACUNAV^™ 10F Siemens Catheter	10F	90 cm	90 cm	Siemens Sequoia^™ Cypress^™, Acuson X300^™, X700^™, SC2000^™
R10135910	Certified Performance ACUNAV^™ 8F GE Catheter	8F	90 cm	90 cm	GE Vivid^™ i, GE Vivid^™ q
R10043342	Certified Performance ACUNAV^™ 10F GE Catheter	10F	90 cm		GE Vivid^™ i, GE Vivid^™ q

About Us Careers Investors Grants

EHS & Transparency Clinical Resources Global Research Reimbursement

Legal Notice Privacy Policy Posting Guidelines

This site is published by Biosense Webster, Inc. which is solely responsible for its content.

This site is intended for Healthcare Professionals residing in the United States.
046549-170929, 046550-170913, 046549-170927

Click here for our California Health Care Compliance Information and AdvaMed Code.

In the U.S., THERMOCOOL^® Navigation Catheters are approved for drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with CARTO^® Systems (excluding NAVISTAR^® RMT THERMOCOOL^® Catheter). Biosense Webster THERMOCOOL^® Catheters are indicated for Type I Atrial Flutter in patients 18 years of age or older.

Bertaglia E, Bella PD, Tondo C, Proclemer A, Bottoni N, De Ponti R, et al. Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation: results from the CARTOMERGE^® Module Italian Registry. Europace 2009;11:1004-1010.

THERMOCOOL^® Navigation Catheters are approved for recurrent drug/device refractory sustained monomorphic ventricular tachycardia (VT) due to prior myocardial infarction (MI) in adults (excluding THERMOCOOL^® SF Catheters).

The NAVISTAR^® THERMOCOOL^® and EZ STEER^® THERMOCOOL^® NAV Catheters are FDA approved for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible three-dimensional electroanatomic mapping systems.

In the US, Biosense Webster THERMOCOOL^® non-navigational Catheters are indicated for the treatment of Type I Atrial Flutter in patients 18 years of age or older.

The clinical significance of utilizing the CARTO^® CFAE Module to help identify areas with complex fractionated atrial electrograms for catheter ablation of atrial arrhythmias, such as atrial fibrillation, has not been established by clinical investigations.

Always verify catheter tip location using fluoroscopy or IC signals and consult the CARTO^® System User Guide regarding recommendations for fluoroscopy use.

Sporton S, Earley M, Nathan A, and Schilling R, Electroanatomic versus fluoroscopic mapping for catheter ablation procedures: A prospective randomized study. Journal of Cardiovascular Electrophysiology 2004;15,3:310-315

The clinical significance of utilizing the PASO^™ Module to help pace mapping for catheter ablation of ventricular arrhythmias has not been demonstrated by clinical investigations.

The CARTO VISITAG^™ Module provides access to data collected during the application of RF energy. The data does not indicate the effectiveness of RF energy application. CARTO VISITAG^™ Module settings are user defined based on the user’s clinical experience and medical judgment. Biosense Webster, Inc. does not recommend any settings for the CARTO VISITAG^™ Module.

In the US, 4mm Catheters (NAVISTAR^®, CELSIUS^®, EZ STEER^® (NAV and Non-Nav)) have a “General Indication” for creation of endocardial lesions in patients 4 years of age and older. This “General Indication” includes treatment of Ventricular Tachycardia.

Third party trademarks used herein are trademarks of their respective owners.

This site last updated on February 15, 2018.

CARTO^® System Solutions

Non-Navigational Products

Electrophysiologist

Cardiologist

All

Sign in to your account

CARTO® System Solutions

Non-Navigational Products

Electrophysiologist

Cardiologist

All

Sign in to your account

CARTO^® System Solutions